479 related articles for article (PubMed ID: 35955405)
21. Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives.
Wang Y; Jin M; Cheng CK; Li Q
Front Endocrinol (Lausanne); 2023; 14():1238927. PubMed ID: 37600689
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches.
Narongkiatikhun P; Chattipakorn SC; Chattipakorn N
J Cell Mol Med; 2022 Jan; 26(2):249-273. PubMed ID: 34889040
[TBL] [Abstract][Full Text] [Related]
23. Targeting the Pathobiology of Diabetic Kidney Disease.
Thomas MC
Adv Chronic Kidney Dis; 2021 Jul; 28(4):282-289. PubMed ID: 34922684
[TBL] [Abstract][Full Text] [Related]
24. New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era.
Hu X; Chen S; Ye S; Chen W; Zhou Y
Front Immunol; 2024; 15():1342837. PubMed ID: 38487541
[TBL] [Abstract][Full Text] [Related]
25. Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism.
Liu T; Jin Q; Yang L; Mao H; Ma F; Wang Y; Li P; Zhan Y
Front Endocrinol (Lausanne); 2023; 14():1142276. PubMed ID: 37635982
[TBL] [Abstract][Full Text] [Related]
26. An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease.
Lin Y; Yang Q; Wang J; Chen X; Liu Y; Zhou T
Front Endocrinol (Lausanne); 2022; 13():962635. PubMed ID: 35966088
[TBL] [Abstract][Full Text] [Related]
27. Optimizing diabetic kidney disease animal models: Insights from a meta-analytic approach.
Li F; Ma Z; Cai Y; Zhou J; Liu R
Animal Model Exp Med; 2023 Oct; 6(5):433-451. PubMed ID: 37723622
[TBL] [Abstract][Full Text] [Related]
28. Diabetic Nephropathy: An Overview.
Sagoo MK; Gnudi L
Methods Mol Biol; 2020; 2067():3-7. PubMed ID: 31701441
[TBL] [Abstract][Full Text] [Related]
29. The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease.
Kourtidou C; Tziomalos K
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983082
[TBL] [Abstract][Full Text] [Related]
30. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.
Pichler R; Afkarian M; Dieter BP; Tuttle KR
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F716-F731. PubMed ID: 27558558
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic role of mesenchymal stem cells (MSCs) in diabetic kidney disease (DKD).
Xu N; Liu J; Li X
Endocr J; 2022 Oct; 69(10):1159-1172. PubMed ID: 35858781
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology of diabetic kidney disease and autophagy: A review.
Yu J; Liu Y; Li H; Zhang P
Medicine (Baltimore); 2023 Jul; 102(30):e33965. PubMed ID: 37505163
[TBL] [Abstract][Full Text] [Related]
33. Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease.
Matoba K; Takeda Y; Nagai Y; Kawanami D; Utsunomiya K; Nishimura R
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295940
[TBL] [Abstract][Full Text] [Related]
34. Role of Immune Cells in Diabetic Kidney Disease.
Yang X; Mou S
Curr Gene Ther; 2017; 17(6):424-433. PubMed ID: 29446740
[TBL] [Abstract][Full Text] [Related]
35. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
[TBL] [Abstract][Full Text] [Related]
36. T cells and their products in diabetic kidney disease.
Liu Y; Lv Y; Zhang T; Huang T; Lang Y; Sheng Q; Liu Y; Kong Z; Gao Y; Lu S; Yang M; Luan Y; Wang X; Lv Z
Front Immunol; 2023; 14():1084448. PubMed ID: 36776877
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease.
Chen X; Li X; Cao B; Chen X; Zhang K; Han F; Kan C; Zhang J; Sun X; Guo Z
Int Urol Nephrol; 2024 Feb; 56(2):571-582. PubMed ID: 37552392
[TBL] [Abstract][Full Text] [Related]
38. Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review.
Das S; Devi Rajeswari V; Venkatraman G; Elumalai R; Dhanasekaran S; Ramanathan G
Transl Res; 2024 Mar; 265():71-87. PubMed ID: 37952771
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress as a culprit in diabetic kidney disease.
Su S; Ma Z; Wu H; Xu Z; Yi H
Life Sci; 2023 Jun; 322():121661. PubMed ID: 37028547
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease.
Mitrofanova A; Fontanella AM; Burke GW; Merscher S; Fornoni A
Cells; 2022 Nov; 11(22):. PubMed ID: 36429063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
